Harrow Health Inc. 8.625%... (HROWL)
25.45
0.04 (0.16%)
At close: Jan 14, 2025, 3:58 PM
25.01
-1.73%
Pre-market Jan 15, 2025, 04:00 AM EST
undefined% (undefined)
| Bid | 25 |
| Market Cap | 1.31B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 25.55 |
| Volume | 4,011 |
| Avg. Volume (20D) | 4,255 |
| Open | 25.42 |
| Previous Close | 25.41 |
| Day's Range | 25.41 - 25.45 |
| 52-Week Range | 23.71 - 25.73 |
| Beta | undefined |
About HROWL
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN....
Industry Medical - Pharmaceuticals
Sector Healthcare
IPO Date May 7, 2021
Employees 217
Stock Exchange NASDAQ
Ticker Symbol HROWL
Website http://www.harrowinc.com